In this issue:
- Cognition and return to work after breast cancer diagnosis
- Recurrence after early breast cancer between 1990 and 2009
- Outcomes from low-risk ductal carcinoma in situ
- Breast Cancer Index in early-stage hormone receptor-positive breast cancer
- Physical activity and breast cancer risk before age 40 years
- Long-term adjuvant trastuzumab for ERBB2-positive breast cancer
- Trastuzumab deruxtecan vs trastuzumab emtansine for HER2-positive breast cancer
- Analysis of HER2-low breast cancer in NZ
- Experiences of women undergoing mastectomy in an acute surgical ward
- Inavolisib in PIK3CA-mutated advanced breast cancer
Please login below to download this issue (PDF)